chrisvoncsefalvay/vaers-outcomes huggingface dataset:
no adverse event; multiple patients were vaccinated with an improperly stored vaccine; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant therapies were not reported.  On 14-JUN-2019, the patient was vaccinated with an improperly stored dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ), 2 ml, orally, LOT# R027157, expiry date 14-JUL-2020 for prophylaxis. The vaccine was exposed to a temperature of 34.2 F for 4 hours and 54 minutes. This call was made because of a digital data logger. There were no previous temperature excursions. No adverse effects were reported.  This is one of several reports from the same reporter.; Sender's Comments:  US-009507513-1906USA011674: US-009507513-1907USA000862: US-009507513-1907USA000882: US-009507513-1907USA000883: US-009507513-1907USA000884: US-009507513-1907USA000886: US-009507513-1907USA000887: US-009507513-1907USA000888: US-009507513-1907USA000889: US-009507513-1907USA000890: US-009507513-1907USA000891: US-009507513-1907USA000892: US-009507513-1907USA000893: US-009507513-1907USA000894: US-009507513-1907USA000895: US-009507513-1907USA000896: US-009507513-1907USA000897: US-009507513-1907USA000898: US-009507513-1907USA000899: US-009507513-1907USA000900: US-009507513-1907USA000901: US-009507513-1907USA000902: US-009507513-1907USA000904: US-009507513-1907USA000905: US-009507513-1907USA000906: US-009507513-1907USA000907: US-009507513-1907USA000908: US-009507513-1907USA000909: US-009507513-1907USA000910: US-009507513-1907USA000911: US-009507513-1907USA000912: US-009507513-1907USA000913: US-009507513-1907USA000914: US-009507513-1907USA000915: US-009507513-1907USA000916: US-009507513-1907USA000917: US-009507513-1907USA000918: US-009507513-1907USA000919: US-009507513-1907USA000920: US-009507513-1907USA000921: US-009507513-1907USA000922: US-009507513-1907USA000923: US-009507513-1907USA000924: US-009507513-1907USA000925: US-009507513-1907USA000926: US-009507513-1907USA000927: US-009507513-1907USA000928: US-009507513-1907USA000929: US-009507513-1907USA000930: US-009507513-1907USA000931: US-009507513-1907USA000932: US-009507513-1907USA000933: US-009507513-1907USA000934: US-009507513-1907USA000935: US-009507513-1907USA000936: US-009507513-1907USA000937: US-009507513-1907USA000938: US-009507513-1907USA000903:
EDD=11/8/2021, IUFD diagnosed 5/12/2021
That evening around 9 or 10 Left arm started to get sore. Saturday morning from sorness to pain. Saturday evening "big, red whelp developed." Sunday morning at its worst, warm to the touch, limited ROM, could not raise arm above shoulder, red mark 6in by 4 in down arm from injection site down arm. Sunday evening not warm to the touch, limited ROM. Monday morning getting better. Red mark continuously fading until Tuesday. Full ROM on Tuesday. On Tuesday no paid only soreness can more arm fully.
I had the Moderna vaccination on Feb 23 and March 23. I had no side effects after the first shot, but I did have side effects with the second shot. About 14 hours (3:00 am on March 24) after the second shot, I awoke to chills followed by muscle aches and a low grade fever 99.7.  I had a headache and continued chills.  Then nausea and vomiting started.  I only vomited once. This all lasted until about 8:00 pm March 24. I have been fine and feeling normal since.
Thigh Red, Swollen, hot to touch - Afebrile TX- warm compress to site three times/day recheck in 24hrs.
The administration site felt hard to the touch, showed redness, minor swelling, and minor itching the following day after administration. An ice pack was used by the patient to relieve itching.  5 days later all symptoms have lessened significantly.
Flu-like symptoms for one week after Vaccine  (Fever, chills, headache, body ache, fatigue.) I am type 1 diabetic.  Saw a significant rise in blood sugars for a month after the vaccine.  I was not prepared for that.  I needed more longterm insulin, and tried to get sugars down with shortterm insulin.
Approximately 3 months post vax, pt developed night sweats, fatigue, fevers, abdominal pain, nausea, headaches, knee pains, and adenopathy that has persisted.
PATIENT CLAIMED THEY BROKE OUT IN FULL BODY RASH AND HIVES.
headache; discomfort around her chest area; This is a spontaneous report from a non-contactable consumer (patient) A female patient of an unspecified age received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number was not reported), on 16Feb2021 at single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported.  The patient experienced headache and discomfort around her chest area on an unspecified date in 2021.Events were non serious.Final outcome of the events was unknown.  Patient wanted to know if she can take Aspirin to treat her headache and the discomfort around her chest area. No follow-up attempts are possible, information about batch number cannot be obtained.
Nausea and vomiting, achiness, dizziness, headache, fever 99.5 (3 days after vaccine). Lasted only 3 hours.
Patient received the Moderna booster. Immediately after receiving vaccine, patient had a syncopal episode. Patient slumped over on chair and was unresponsive for approximately 5 seconds. When patient regained became responsive she was immediately moved to a bed and vitals were taken on site. BP 103/56, HR 50, SPO2 98%, A&Ox4. Patient was given water and juice and was monitored for the next 30 minutes. Repeat vitals BP 110/68, HR 70, SPO2 98. Per patient this has happened before in the past. Patient was discharged without further incident.
2/9/2021 2nd dose moderna vaccine received; 2/10/21  3 AM nose bleed; 2/11/21 3-5 AM nose bleed
For Two days following vaccine: Fever, chills, body aches, headache, fatigue, nausea, muscle pain, dizziness, dry mouth dehydration, pain at injection site For Four days following vaccine: fatigue, dizziness, abdominal pain, diarrhea, nausea, pain at injection site. Pain at injection site is ongoing
Left chest wall pain over medial clavicle, onset 5 hours after shots. Treatment with Ibu 600 mg tid and ice therapy and rest. Symptoms initially severe, with gradual improvement of symptoms over a 2 week period. No erythema or swelling at injection site or over the clavicle.
This spontaneous report as received from a registered nurse refers to a 14 year old patient of unknown gender. Concurrent conditions and medical history were not provided. On 30-MAY-2014, the patient ws vaccinated with M-M-R II (lot # 0644AE, expiration date 27-MAR-2014) (dose, dose number and route were not provided). No adverse effects reported. Additional information has been requested.
1 week, post vax, she spiked a fever of 104F with extreme behavior changes such as tantrums, screaming and crying. Never did these things prior to vaccines; completely different personality. Seen by Dr twice; once in ER and a total of 3 and still ill on 11/8/00.
This spontaneous report as received from a healthcare worker refers to unknown number of patients of unknown age and gender. On an unknown date, the patients might have been vaccinated with RECOMBIVAX HB that was exposed to temperatures below 36 degrees F for an unknown amount of time. No adverse effect was reported. This is one of several reports from the same source. Additional information has been requested.
Patient developed a raised red circle and warm to touch immediately after receiving  vaccine and 3 days later still continues to have a red raise circle on arm and itchiness.
Confirmed Breakthrough Case: COVID-19 (Moderna) 1- 01/27/2021 Moderna 012L20A   COVID-19 (Moderna) 2- 03/24/2021 Moderna 023M20A   COVID-19 (Moderna) 3- 01/12/2022 Moderna 060H21A
Patient started with blood in stool next day after receiving 1st dose; A spontaneous report was received from a consumer concerning a 43-year-old, male patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced blood in stool next day after receiving 1st dose.  The patient's medical history as provided by the reporter included hypertension. Concomitant medications reported included blood pressure medication.  On 17 Mar 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Batch number: Unknown) intramuscularly for prophylaxis of COVID-19 infection.   On 18 Mar 2021, patient had blood in stool next day after receiving 1st dose. The event was considered medically significant.  Lab details were not provided by the reporter.  Treatment information was not provided.  Action taken with mRNA-1273 in response to the event was not reported.  The outcome of the event, patient started with blood in stool next day after receiving 1st dose was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the onset date of the reported event, a causal relationship cannot be excluded.
Woke up feeling extreme dizziness, room spining, cold clammy to touch.
Body aches; Sore arm; Fatigue; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body aches), PAIN IN EXTREMITY (Sore arm), FATIGUE (Fatigue) and CHILLS (Chills) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical History.     On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN (Body aches), PAIN IN EXTREMITY (Sore arm), FATIGUE (Fatigue) and CHILLS (Chills). The patient was treated with IBUPROFEN ongoing from 27-Mar-2021 at an unspecified dose and frequency. At the time of the report, PAIN (Body aches), PAIN IN EXTREMITY (Sore arm), FATIGUE (Fatigue) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
7 days after injection, I was playing tennis in rather hot weather and when I got home, hives were present all around the injection site.  No other adverse reactions.  No treatment.
LEG PAIN; FATIGUE; FEVER; DIZZY; This spontaneous report received from a parent concerned a 21 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 043A21A expiry: UNKNOWN) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 07-APR-2021, the subject experienced dizzy. On 07-APR-2021, the subject experienced fatigue. On 07-APR-2021, the subject experienced fever. On 08-APR-2021, the subject experienced leg pain. On 16-APR-2021, Laboratory data included: Diagnostic ultrasound (NR: not provided) Not had clots. Treatment medications (dates unspecified) included: ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from dizzy, fatigue, and fever on 08-APR-2021, and leg pain. This report was non-serious.
97-year-old male with a past medical history of CKD 3, PVD, hypertension, diabetes not on medication, CHF, hypertension who is a resident of an assisted living facility. He then felt the room was spinning he returned back to his bed and sat down on the edge of the bed and slid off and fell to the floor and could not get up.  He did not hit his head and he did not have any loss of consciousness.  Chest x-ray showed no acute abnormality. Found to be COVID + , but did not have any respiratory symptoms. Required 1.5L for a few hours (saturation was 98% so I question if he even needed it). He was given Decadron x 10 days.
hives on legs, top of the arm; swollen lips/lip swelled really big; This is a spontaneous report from a contactable consumer (patient) via medical information team. A 64-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, lot number: EP6955) via an unspecified route of administration in left arm on 19Mar2021 at 09:00 as single dose for COVID-19 immunization in pharmacy. Medical history included back pain, fibromyalgia, restless leg syndrome (all started 15-20 years ago), depression from 1987, hyperthyroidism (diagnosed 15 years ago), headache (started off and on for 30 years; last 15 years), all were ongoing. She fell and had a blood clot in her ankle. She broke her right arm and she isn't sure if the blood clot was from the broken arm or not. This all happened before her Covid Vaccine. Concomitant medications included ongoing gabapentin oral at 400 mg, four times a day (started 15 years ago) for restless leg syndrome, fluoxetine 40 mg, once a day (taken ever since it came out on the market, that was in 1987-1988) for depression, methimazole oral 1 tablet orally alternate day (every other day) for thyroid, topiramate oral at 200mg one tablet twice a day (been on at least 10 years) for headache, apixaban (ELIQUIS) from Feb2021 at 5 mg twice a day for blood Thinner and Hydrocodone 10/325mg; takes 4-5 times a day, for back pain and fibromyalgia. On 29Mar2021, patient experienced hives on legs, top of the arm, swollen lips about 10 days after in evening. Her lip swelled really big. She looked like someone who got Botox 3 times too much in her upper lip. She took Benadryl, states it is not worth a crap. A visit to emergency room and physician office was not required. The outcome of event hives was recovered on 07Apr2021; Lip Swelled Really Big was recovered on 08Apr2021.  No follow up attempts are needed; No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021474640 Same patient, same product in different dose, different events
received three Pfizer BioNTech for kids the vaccines and all three boxes are expired; administered to 5 kids yesterday; This is a spontaneous report from a contactable Pharmacist. This Pharmacist reported  similar events for 5 patients. This is 2nd of 5 reports. This Pharmacist reported for a patient that:  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date 06Nov2021 (Lot number: FK5127, Expiration Date: Aug2021) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: EXPIRED PRODUCT ADMINISTERED (non-serious), outcome "unknown", described as "received three Pfizer BioNTech for kids the vaccines and all three boxes are expired; administered to 5 kids yesterday".  Follow-up attempts are completed. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101534342 Same product and event, different patient
When I woke up, I felt pain throughout my body. The injection site was especially sensitive, and it was throbbing. I had no appetite. No desire to get out of bed. Just sleep. All my chronic illnesses ? those all came up. I had several migraines; I didn?t take laxatives because I didn?t eat. I had a lot of pain with my hip and back. It?s like it had gotten worse. It was a reaction that my body was having. It was like emergency, you?re sick. My body was putting out everything I got to get rid of it. My immune system was present and doing its job very powerfully. It just resulted in me not getting up, not move, not wake up or eat. I did not want to do anything but sleep. I just hurt. That lasted for 4 days. I wasn?t in any kind of physical danger, so I just rode out the symptoms. I knew it would get better and I could call a doctor if I needed one. So I just decided to sleep and let myself be. The symptoms just slowly eased away over time. Frequency may be considered for age groups when getting the vaccines- that way people may not get sick after.
A report has been received from a Health Professional concerning a series of unidentifiable patients of unknown gender, who have been receiving Nasal FLUMIST. FLUMIST was administered during Jan-2013. The patients were ADMINISTERED EXPIRED FLUMIST during Jan-2013. Lot number unknown, expiration date 14-Jan-2013. The outcome of the event of unknown. The report was considered to be EXPIRED FLUMIST ADMINISTERED is  non-serious by the reporter.
chills, runny nose, ach y bones, eyes bloodshot for 2 days;
patient tested positive after receiving the first dose; This is a spontaneous report from a contactable consumer (patient's parent). A 37-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 via an unspecified route of administration, administered in left arm on 09Apr2021 (lot number: ER8733) at the age of 37 years old, as single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported.  The patient tested positive for COVID-19 after receiving the first dose on 13Apr2021 with outcome of not recovered.
I was on the phone with my father at about 1 pm on 11/10/21 and he couldn?t get the words out to answer me. He went to the emergency room. He had had a stroke.
I did not have an adverse reaction to the vaccine, I am just trying to report a break through covid 19 infection.  Because I have CLL and was taking Imbruvica, I had heard it may have affected the vaccine's efficacy, so I joined a study with the Leukemia and Lymphoma society and found I only go 19 antibodies.  While apparently not enough to stop the infection, I never got so bad the I felt I required hospitalization.
Starting four hours after the vaccination I became fatigued and this lasted through the next day. I started getting headaches the day after the vaccine and took ibuprofen once to treat those. On 1/27, I developed a swollen, red lump about 2-3 inches in diameter around the injection site. My whole right arm was swollen and tingly and the red lump was itchy, uncomfortable to touch, and hot. On 1/27, I also got severe headaches and muscle pain in my neck, right shoulder, and back. I visited a nurse practitioner who thought this to be an skin infection developed from the introduction of bacteria in some way during the vaccine, and she prescribed cephalexin to treat it. After two days of taking the antibiotic, the redness and swelling subsided, along with the other symptoms. Now I am reading that other had similar delayed hypersensitivities in response to this vaccine and believe this was actually a reaction to the vaccine and not an infection.
Patient did not receive second dose within the recommended window/received the 1st dose of the Moderna COVID-19 vaccine on 01May2021, It's been 3 months; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 02-Aug-2021 and was forwarded to Moderna on 02-Aug-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Patient did not receive second dose within the recommended window/received the 1st dose of the Moderna COVID-19 vaccine on 01May2021, It's been 3 months) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Patient did not receive second dose within the recommended window/received the 1st dose of the Moderna COVID-19 vaccine on 01May2021, It's been 3 months). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Patient did not receive second dose within the recommended window/received the 1st dose of the Moderna COVID-19 vaccine on 01May2021, It's been 3 months) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment medications were reported.
Information has been received from a registered nurse concerning a 50 year old female who on 14-NOV-2006 was vaccinated with a 0.5 mL dose of Pneumovax 23 (Lot# 655291/0985F). Concomitant therapy included albuterol, "L-Tab", MOTRIN, "Norontin", PREVACID and ROBAXIN. After vaccination on 14-NOV-2006, that evening the patient had a temperature and redness towards outer portion of the arm approximately 3 centimeters in diameter below the injection site. The patient outcome was not reported. The patient sought unspecified medical attention. Additional information is not expected.
On 11/20/00, pt had upper respiratory infection associated with cough, sore throat, wheezing, low-grade temperature and chills with profuse sweating. She kept getting worse and was hospitalized on 12/29/00. On 1/25/00, she had numbness in hands and feet, trouble walking, drooping on the left side of face with slurred speech, asymmetric smile, numb tongue, blurred vision and trouble with eyelids. She was hospitalized and put on IVIG for 5 days. She is still recovering and taking physical therapy. The follow up states that: I have permanent facila damage (the left side of my face does not move); have visual problems; hand, feet and legs still go numb; also still have lung problems. This shot has left me physically and mentally impaired.
This is a spontaneous report received from a noncontactable consumer or other non-HCP (parent). A 19-day-old patient received the 1st dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, batch/lot# FC3181), on Sep 10, 2021, at 12:45, and received the 2nd dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, batch/lot# FF2588), on Oct 1, 2021, at 12:30; both single dose and transmammary, for COVID-19 immunisation. The mother of the patient was 30 years old at the time of vaccination. No medical history reported. Concomitant medication included dicloxacillin. The patient had exposure via breast milk/breastfeeding, onset Sep 15, 2021, with outcome of unknown. No follow-up attempts possible. No further information expected. Sender's comments: Linked report: US-PFIZER INC-202101327993 mother/baby case.
pt recv vax & devel t102 to 104;pt states has not felt good since;eyes bothers pt & head hurst;feel dizzy & weak;don't eat very much;